Effect of collaborative quality improvement on stillbirths, neonatal mortality and newborn care practices in hospitals of Telangana and Andhra Pradesh, India: evidence from a quasi-experimental mixed-methods study.

Evidence-based practices India Neonatal mortality Newborn care Quality improvement Sick newborn babies

Journal

Implementation science : IS
ISSN: 1748-5908
Titre abrégé: Implement Sci
Pays: England
ID NLM: 101258411

Informations de publication

Date de publication:
07 01 2021
Historique:
received: 19 06 2020
accepted: 19 10 2020
entrez: 8 1 2021
pubmed: 9 1 2021
medline: 26 10 2021
Statut: epublish

Résumé

Improving quality of care is a key priority to reduce neonatal mortality and stillbirths. The Safe Care, Saving Lives programme aimed to improve care in newborn care units and labour wards of 60 public and private hospitals in Telangana and Andhra Pradesh, India, using a collaborative quality improvement approach. Our external evaluation of this programme aimed to evaluate programme effects on implementation of maternal and newborn care practices, and impact on stillbirths, 7- and 28-day neonatal mortality rate in labour wards and neonatal care units. We also aimed to evaluate programme implementation and mechanisms of change. We used a quasi-experimental plausibility design with a nested process evaluation. We evaluated effects on stillbirths, mortality and secondary outcomes relating to adherence to 20 evidence-based intrapartum and newborn care practices, comparing survey data from 29 hospitals receiving the intervention to 31 hospitals expected to receive the intervention later, using a difference-in-difference analysis. We analysed programme implementation data and conducted 42 semi-structured interviews in four case studies to describe implementation and address four theory-driven questions to explain the quantitative results. Only 7 of the 29 intervention hospitals were engaged in the intervention for its entire duration. There was no evidence of an effect of the intervention on stillbirths [DiD - 1.3 percentage points, 95% CI - 2.6-0.1], on neonatal mortality at age 7 days [DiD - 1.6, 95% CI - 9-6.2] or 28 days [DiD - 3.0, 95% CI - 12.9-6.9] or on adherence to target evidence-based intrapartum and newborn care practices. The process evaluation identified challenges in engaging leaders; challenges in developing capacity for quality improvement; and challenges in activating mechanisms of change at the unit level, rather than for a few individuals, and in sustaining these through the creation of new social norms. Despite careful planning and substantial resources, the intervention was not feasible for implementation on a large scale. Greater focus is required on strategies to engage leadership. Quality improvement may need to be accompanied by clinical training. Further research is also needed on quality improvement using a health systems perspective.

Sections du résumé

BACKGROUND
Improving quality of care is a key priority to reduce neonatal mortality and stillbirths. The Safe Care, Saving Lives programme aimed to improve care in newborn care units and labour wards of 60 public and private hospitals in Telangana and Andhra Pradesh, India, using a collaborative quality improvement approach. Our external evaluation of this programme aimed to evaluate programme effects on implementation of maternal and newborn care practices, and impact on stillbirths, 7- and 28-day neonatal mortality rate in labour wards and neonatal care units. We also aimed to evaluate programme implementation and mechanisms of change.
METHODS
We used a quasi-experimental plausibility design with a nested process evaluation. We evaluated effects on stillbirths, mortality and secondary outcomes relating to adherence to 20 evidence-based intrapartum and newborn care practices, comparing survey data from 29 hospitals receiving the intervention to 31 hospitals expected to receive the intervention later, using a difference-in-difference analysis. We analysed programme implementation data and conducted 42 semi-structured interviews in four case studies to describe implementation and address four theory-driven questions to explain the quantitative results.
RESULTS
Only 7 of the 29 intervention hospitals were engaged in the intervention for its entire duration. There was no evidence of an effect of the intervention on stillbirths [DiD - 1.3 percentage points, 95% CI - 2.6-0.1], on neonatal mortality at age 7 days [DiD - 1.6, 95% CI - 9-6.2] or 28 days [DiD - 3.0, 95% CI - 12.9-6.9] or on adherence to target evidence-based intrapartum and newborn care practices. The process evaluation identified challenges in engaging leaders; challenges in developing capacity for quality improvement; and challenges in activating mechanisms of change at the unit level, rather than for a few individuals, and in sustaining these through the creation of new social norms.
CONCLUSION
Despite careful planning and substantial resources, the intervention was not feasible for implementation on a large scale. Greater focus is required on strategies to engage leadership. Quality improvement may need to be accompanied by clinical training. Further research is also needed on quality improvement using a health systems perspective.

Identifiants

pubmed: 33413504
doi: 10.1186/s13012-020-01058-z
pii: 10.1186/s13012-020-01058-z
pmc: PMC7788546
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4

Subventions

Organisme : Medical Research Council UK
ID : MR/N013638/1

Références

Qual Manag Health Care. 1998 Sep;6(4):1-13
pubmed: 10339040
Glob Health Action. 2019;12(1):1581466
pubmed: 30849300
Matern Health Neonatol Perinatol. 2019 Mar 1;5:3
pubmed: 30867935
BMC Health Serv Res. 2020 Jun 8;20(1):522
pubmed: 32513236
Implement Sci. 2017 Jul 18;12(1):89
pubmed: 28720114
BMJ Open. 2015 Apr 28;5(4):e006211
pubmed: 25922094
BMC Pregnancy Childbirth. 2014 May 24;14:174
pubmed: 24885817
Ann Intern Med. 2004 Jun 1;140(11):887-96
pubmed: 15172903
Implement Sci. 2017 Jun 21;12(1):77
pubmed: 28637486
PLoS One. 2018 Dec 19;13(12):e0209092
pubmed: 30566511
Trials. 2014 Jul 05;15:267
pubmed: 24996765
Lancet Glob Health. 2018 Nov;6(11):e1196-e1252
pubmed: 30196093
Lancet Glob Health. 2019 Aug;7(8):e1088-e1096
pubmed: 31303296
Implement Sci. 2015 Apr 16;10:49
pubmed: 25885787
Indian Pediatr. 2018 Sep 15;55(9):824-827
pubmed: 30345993
Implement Sci. 2009 May 21;4:29
pubmed: 19460163
Implement Sci. 2012 Aug 28;7:77
pubmed: 22929925
PLoS Med. 2019 Jul 23;16(7):e1002860
pubmed: 31335869
PLoS One. 2019 Oct 3;14(10):e0221919
pubmed: 31581197
BMJ Qual Saf. 2014 Apr;23(4):290-8
pubmed: 24025320
PLoS One. 2013 May 07;8(5):e60694
pubmed: 23667427
Int J Epidemiol. 1999 Apr;28(2):319-26
pubmed: 10342698
Int Health. 2013 Sep;5(3):180-95
pubmed: 24030269
Soc Sci Med. 2012 Dec;75(12):2299-306
pubmed: 22989491
BMJ Qual Saf. 2011 Aug;20(8):658-65
pubmed: 21317182
Natl Med J India. 2011 Nov-Dec;24(6):335-41
pubmed: 22680257
J Perinatol. 2016 Dec;36(s3):S18-S23
pubmed: 27924106
BMC Med. 2010 Oct 20;8:63
pubmed: 20961442
Lancet Glob Health. 2018 Nov;6(11):e1163-e1175
pubmed: 30309799
Trials. 2013 Jan 12;14:15
pubmed: 23311722
Milbank Q. 2011 Jun;89(2):167-205
pubmed: 21676020
Implement Sci. 2020 May 4;15(1):27
pubmed: 32366269
Implement Sci. 2011 Apr 23;6:42
pubmed: 21513547
Health Aff (Millwood). 2005 Jan-Feb;24(1):138-50
pubmed: 15647225
BMJ Qual Saf. 2018 Mar;27(3):226-240
pubmed: 29055899
Lancet Glob Health. 2020 Aug;8(8):e1061-e1070
pubmed: 32710862
Lancet. 2017 May 6;389(10081):1784
pubmed: 28495157
N Engl J Med. 2017 Dec 14;377(24):2313-2324
pubmed: 29236628

Auteurs

Karen Zamboni (K)

Department of Disease Control, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK. Karen.zamboni@lshtm.ac.uk.

Samiksha Singh (S)

Public Health Foundation, India, Kavuri Hills, Madhapur, Hyderabad, India.

Mukta Tyagi (M)

Public Health Foundation, India, Kavuri Hills, Madhapur, Hyderabad, India.

Zelee Hill (Z)

Institute for Global Health, University College London, London, UK.

Claudia Hanson (C)

Department of Disease Control, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.

Joanna Schellenberg (J)

Department of Disease Control, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH